Apoptosis related microRNAs and MGMT in glioblastoma cell lines submitted to treatments with ionizing radiation and temozolomide

被引:5
|
作者
Trevisan, Felipe Amstalden [1 ]
Rodrigues, Andressa Romualdo [2 ]
Lizarte Neto, Fermino Sanches [1 ]
Peria, Fernanda Maris [3 ]
de Assis Cirino, Mucio Luiz [1 ]
da Cunha Tirapelli, Daniela Pretti [1 ]
Carlotti Junior, Carlos Gilberto [1 ]
机构
[1] Univ Sao Paulo, Med Sch Ribeirao Preto, Dept Surg & Anat, 3900 Bandeirantes Ave, BR-14049900 Ribeirao Preto, Brazil
[2] Univ Franca UNIFRAN, Med Sch Franca, 201 Armando Salles Oliveira Ave, BR-14404600 Franca, SP, Brazil
[3] Univ Sao Paulo, Med Sch Ribeirao Preto, Dept Internal Med, 3900 Bandeirantes Ave, BR-14049900 Ribeirao Preto, Brazil
关键词
Glioblastoma; microRNAs; Ionizing radiation; Apoptosis; HEALTH-ORGANIZATION CLASSIFICATION; NERVOUS-SYSTEM; U87MG CELLS; MULTIFORME; TUMORS; PROGNOSIS; PATHWAYS; IDH1;
D O I
10.1016/j.rpor.2020.06.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: To evaluate the effect of radiotherapy and temozolomide on the expression of miRNAs apoptotic (miRNAs-21, -221, -222 (anti-apoptotic) and miRNAs-15a, -16 (pro-apoptotic)) and the gene MGMT in glioblastoma cell lines. Background: The limited knowledge of the molecular biology of malignant gliomas may hinder the development of therapeutic modalities. In this scenario, one of the greatest advances of recent years was the identification of microRNAs. These molecules have an important role in biological processes involving cancer, including glioblastoma. Materials and methods: Trypan blue was used to verify the cell viability, and real time PCR to quantify the expression of microRNAs and gene 24, 48 and 120 h after exposure to treatments. Results: There was a statistically significant decrease of expression of miR-15a between 48 and 120 h in line T98 G treated with radiation, increased expression of miR-15a between 24 and 120 h in line U251 treated with radiation and temozolomide, and increased expression of miR-16 between 24 and 120 h in line U251 treated with radiation alone and when combined with temozolomide. There was a decrease in MGMT gene expression, between 24 and 48 h in U343 cells treated with temozolomide. Conclusions: Ionizing radiation and temozolomide modified the expression of miRNAs studied and MGMT. (C) 2020 Greater Poland Cancer Centre. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:714 / 719
页数:6
相关论文
共 50 条
  • [1] Expression of microRNAs associated with apoptosis in neurospheres of glioblastoma cell line subjected to treatment with ionizing radiation and temozolomide.
    Schiavoni, Vagner Sarraipo
    Rodrigues, Andressa Romualdo
    de Assis Cirino, Mucio Luiz
    Lizarte Neto, Fermino Sanzes
    da Cunha Lourenco, Luana Pretti
    Peria, Fernanda Maris
    Bisson, Gabriela Silva
    Tiezzi, Daniel Guimaraes
    Tirapelli, Luis Fernando
    Carlotti Junior, Carlos Gilberto
    da Cunha Tirapelli, Daniela Pretti
    FASEB JOURNAL, 2018, 32 (01):
  • [2] microRNA-181d associated with the methylation status of the MGMT gene in Glioblastoma multiforme cancer stem cells submitted to treatments with ionizing radiation and temozolomide
    Lizarte Neto, Fermino Sanches
    Rodrigues, Andressa Romualdo
    Trevisan, Felipe Amstalden
    de Assis Cirino, Mucio Luiz
    Marconato Simoes Matias, Caio Cesar
    Pereira-da-Silva, Gabriela
    Peria, Fernanda Maris
    da Cunha Tirapelli, Daniela Pretti
    Carlotti, Carlos Gilberto, Jr.
    BRAIN RESEARCH, 2019, 1720
  • [3] CELL DEATH MODALITIES INDUCED BY SINGLE OR COMBINED TREATMENTS WITH RADIATION AND TEMOZOLOMIDE IN GLIOBLASTOMA CELL LINES
    Pasi, F.
    Paolini, A.
    Facoetti, A.
    Mazzini, G.
    Nano, R.
    CYTOMETRY PART A, 2011, 79A (12) : 1033 - 1034
  • [4] Modulation of Genes and MicroRNAs in the Neurospheres of Glioblastoma Cell Lines U343 and T98G Induced by Ionizing Radiation and Temozolomide Therapy
    Da Costa Almeida, Thiago L.
    Rodrigues, Andressa R.
    Cirino, Mucio
    Trevisan, Felipe A.
    Peria, Fernanda
    Tirapelli, Daniela
    Carlotti Jr, Carlos Gilberto
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (12)
  • [5] Bortezomib overcomes MGMT-related resistance of glioblastoma cell lines to temozolomide in a schedule-dependent manner
    Vlachostergios, Panagiotis J.
    Hatzidaki, Eleana
    Befani, Christina D.
    Liakos, Panagiotis
    Papandreou, Christos N.
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (05) : 1169 - 1181
  • [6] Bortezomib overcomes MGMT-related resistance of glioblastoma cell lines to temozolomide in a schedule-dependent manner
    Panagiotis J. Vlachostergios
    Eleana Hatzidaki
    Christina D. Befani
    Panagiotis Liakos
    Christos N. Papandreou
    Investigational New Drugs, 2013, 31 : 1169 - 1181
  • [7] Global expression of microRNAs in neurospheres in primary cultures of glioblastoma treated with temozolomide and ionizing radiation.
    de Assis Cirino, Mucio Luiz
    Rodrigues, Andressa Romualdo
    Sabedot, Thais Sarraf
    Lizarte Neto, Fermino Sanches
    Pugliesi, Renata
    Peria, Fernanda Maris
    Bisson, Gabriela Silva
    Noushmehr, Houtan
    Tiezzi, Daniel Guimaraes
    Carlotti Junior, Carlos Gilberto
    da Cunha Tirapelli, Daniela Pretti
    FASEB JOURNAL, 2018, 32 (01):
  • [8] Differential radiosensitizing potential of temozolomide in mgmt promoter methylated glioblastoma multiforme cell lines
    Van Nifterik, Krista A.
    Van den Berg, Jaap
    Stalpers, Lukas J. A.
    Lafleur, M. Vincent M.
    Leenstra, Sieger
    Slotman, Ben J.
    Hulsebos, Theo J. M.
    Sminia, Peter
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (04): : 1246 - 1253
  • [9] Influence of MGMT Expression on the Radiation Sensitivity of human Glioblastoma Cell Lines
    Kirstein, A.
    Schilling, D.
    Combs, S. E.
    Schmid, T. E.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (SUPPL 1) : S185 - S185
  • [10] Influence of MGMT expression on the radiation response in different Glioblastoma multiforme cell lines
    Kirstein, A.
    Schilling, D.
    Anastasov, N.
    Raulefs, S.
    Combs, S. E.
    Schmid, T. E.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 : S162 - S163